Exhibit 18 December 2, 2002 BioTime, Inc. 935 Pardee Street Berkeley, California 94710 Attention: Paul Segall, Chief Executive Officer RE: Financial Adviser Agreement Dear Paul: This letter sets forth the terms on which the letter agreement between...Financial Adviser Agreement • December 4th, 2002 • Greenbelt Corp /Ny • Biological products, (no disgnostic substances)
Contract Type FiledDecember 4th, 2002 Company Industry
JOINT FILING AGREEMENTJoint Filing Agreement • December 4th, 2002 • Greenbelt Corp /Ny • Biological products, (no disgnostic substances)
Contract Type FiledDecember 4th, 2002 Company IndustryIn accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the common stock, no par value, of BioTime Inc., and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof, the undersigned, hereby execute this Agreement this 3rd day of December, 2002.